INCR InterCure Ltd: תחזית צמיחת רווח נקי למניה לשנה הבאה
The medical cannabis sector remains stable due to strict compliance and exclusive contracts held by InterCure Ltd. (INCR). Leading positions in Israel and the EU are sustained by competent management focused on expansion. Stable cash flow secures its status as the largest distributor with an extensive pharmacy network. This chart of consensus EPS growth estimates for the coming year demonstrates market expectations, where 0.00 expresses the current value of the metric.
InterCure - פילוחים אנליטיים ומדדי מפתח (INCR)
InterCure Ltd. (INCR) international expansion through partnerships with European brands directly determines the future profitability of the business. This metric aggregates analysts' consensus forecasts for changes in earnings per share, measuring the year-over-year growth rates of net income. Analyzing the one-year forward EPS growth rate allows for an assessment of the company's resilience to market cycles and the risk of asset overvaluation.
